The effect of intravenous iron on hemoglobin levels and outcomes of coronary artery bypass graft surgery.. Other specified complications of cardiac and vascular prosthetic devices, implants and grafts
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, patients will receive an intravenous iron infusion (20 mg/kg) one day before surgery over a 30-minute period (Ferinject vial 10 mL/50 mg
distributed by Bersian Darou). During the infusion and for 30 minutes afterward, patients will be monitored for blood pressure and blood oxygen saturation. Intervention 2: Control group: In the contro
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Iron deficiency anemia (Hemoglobin <12 in woman, Hemoglobin <13 in man and Fretin <30 ) Patients over 18 years old who are candidates for coronary artery bypass surgery EF between 25-55 percent
Exclusion criteria
Exclusion criteria: Severe anemia (hemoglobin < 10 g/dL)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin values. Timepoint: Before coronary artery bypass graft surgery and 2, 4 and 7 days after coronary artery bypass graft surgery. Method of measurement: Complete Blood Count test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient’s need for transfusion. Timepoint: Days before coronary artery bypass graft surgery and 2, 4, 7 days after coronary artery bypass graft surgery. Method of measurement: Complete Blood Count test.;Duration of hospitalization. Timepoint: After the operation. Method of measurement: Based on checklist.;Mortality rate. Timepoint: 30 days after discharge. Method of measurement: Based on checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Vali Imantalab
Rasht University of Medical Sciences
Outcome results
None listed